WallStreetZenWallStreetZen

NASDAQ: CCCC
C4 Therapeutics Inc Stock Ownership - Who owns C4 Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have C4 Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donna Roy GroganDirector2026-04-015,370$2.70
$14.50kBuy
Kenneth Carl AndersonDirector2026-04-014,259$2.70
$11.50kBuy
Andrew HirschPresident CEO2026-02-159,057$1.89
$17.12kSell
Kelly SchickChief People Officer2026-02-147,269$1.89
$13.74kSell
Kendra AdamsChief Financial Officer2026-02-1415,381$1.89
$29.07kSell
Scott N. BoyleChief Business Officer2026-02-147,269$1.89
$13.74kSell
Andrew HirschPresident CEO2026-02-1439,154$1.89
$74.00kSell
Paige MahaneyChief Scientific Officer2026-02-142,446$1.89
$4.62kSell
Mark MosslerChief Accounting Officer2026-02-143,268$1.89
$6.18kSell
Leonard ReynoChief Medical Officer2026-02-1416,579$1.89
$31.33kSell

1 of 3

CCCC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CCCC insiders and whales buy or sell their stock.

CCCC Shareholders

What type of owners hold C4 Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Point72 Asset Management LP9.67%9,439,328$23.93MInstitution
Morgan Stanley9.20%8,981,662$22.77MInstitution
Marc A. Cohen8.52%8,308,874$21.06MInsider
Ra Capital Management LP8.20%8,000,000$20.28MInstitution
Bain Capital Life Sciences Investors LLC7.35%7,171,910$18.18MInstitution
Lynx1 Capital Management LP7.27%7,098,133$17.99MInstitution
Alain J. Cohen6.25%6,094,001$15.45MInsider
Vanguard Group Inc4.49%4,379,815$11.10MInstitution
Wasatch Advisors LP4.45%4,344,918$11.01MInstitution
Soleus Capital Management LP3.90%3,803,942$9.64MInstitution

1 of 3

CCCC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CCCC79.95%20.05%Net SellingNet Selling
TENX40.48%46.56%Net Buying
CGEN13.32%0.32%Net BuyingNet Buying
CHRS34.23%14.29%Net SellingNet Selling
OBIO37.08%61.27%Net BuyingNet Selling
View Top Biotech Stocks

C4 Therapeutics Stock Ownership FAQ

Who owns C4 Therapeutics?

C4 Therapeutics (NASDAQ: CCCC) is owned by 81.82% institutional shareholders, 20.51% C4 Therapeutics insiders, and 0.00% retail investors. Marc A. Cohen is the largest individual C4 Therapeutics shareholder, owning 8.31M shares representing 8.52% of the company. Marc A. Cohen's C4 Therapeutics shares are currently valued at $21.06M.

If you're new to stock investing, here's how to buy C4 Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.